出版社：Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
摘要：Introduction: The whole world is still experiencing a health emergency caused by the pandemic of the new SARS-Cov-2 coronavirus, recently, ivermectin, previously shown to have broad-spectrum antiviral activity in vitro, has been shown to be an inhibitor of the SARS-CoV-2 virus , in this scenario, the article aims to analyze the pharmaceutical performance in drugstores, and compare the pattern of consumption of the drug Ivermectin in the period of the Covid-19 pandemic in the city of Redeno-PA. Methods: An exploratory, retrospective descriptive study was carried out, with the methodological documental procedure in the evaluation of sales records of 05 (five) drugstores in the city of Redeno-PA on the indiscriminate use of ivermectin during the pandemic. The study was carried out by reviewing the sales reports issued in 3 (three) months, namely: March/April/May 2019/2020/2021, respectively. Results and discussion: During the study, a jump in the consumption of ivermectin was observed in 2020, due to the intense search for curative or preventive measures by Covid-19. On the other hand, we recorded a drop in sales of this medication in 2021, due to vaccination in Brazil and the performance of studies that highlight that in none of them the in vivo action of the medication was proven. Final Considerations: It is up to the pharmacist, the last link between the medication and the patient, to guide and prevent the indiscriminate use of ivermectin, since there is enough data to abandon the use of these medications, due to overwhelming evidence that they do not help in the treatment.
